Adam Heckman is a lawyer and patent agent in Gowling WLG's Ottawa office, and a member of the firm's Intellectual Property Litigation and Life Sciences groups.
Adam primarily practices in the area of patents, trademarks and copyright, with a particular focus on patent litigation. Adam has appeared in the Federal Court and Federal Court of Appeal on behalf of a variety of innovative pharmaceutical and biotechnology companies to enforce and defend their intellectual property rights.
In addition to representing clients in patent infringement and impeachment actions, judicial reviews, and proceedings brought under the Patented Medicines (Notice of Compliance) Regulations, Adam also regularly advises pharmaceutical clients on regulatory matters relating to the Food and Drugs Regulations, patent listing, data protection, certificates of supplementary protection, and issues related to the Patented Medicine Prices Review Board.
Adam was recognized in Best Lawyers: Ones to Watch for work in Intellectual Property Law in 2021 and 2022. He was also counsel for the successful party in one of Managing Intellectual Property (MIP) 2022's "Impact Cases of the Year," before the Federal Court of Appeal.
Prior to joining Gowling WLG, Adam worked as a scientist for an international pharmaceutical development and manufacturing service provider and as a quality assurance associate for an innovative pharmaceutical company.
Adam graduated with a JD from Osgoode Hall Law School, where he won various awards for his academic achievements. He also has a graduate certificate in pharmaceutical regulatory affairs and quality operations, and an honours bachelor of science, specializing in pharmaceutical chemistry.